77 related articles for article (PubMed ID: 8868116)
1. Lack of antibodies to the envelope glycoproteins of hepatitis C virus in immunoglobulin preparations from screened donors.
Piazza M; Chien D; Quan S; Houghton M
Boll Soc Ital Biol Sper; 1996; 72(1-2):69-70. PubMed ID: 8868116
[No Abstract] [Full Text] [Related]
2. Detection of antibody to hepatitis C virus E2 recombinant antigen among samples indeterminate for anti-HCV after wide serological testing and correlation with viremia. The Spanish Study Group for Blood Donors at Risk of Transmission of HCV.
León P; López JA; Elola C; Domingo CJ; Echevarria JM
Vox Sang; 1996; 70(4):213-6. PubMed ID: 9123926
[TBL] [Abstract][Full Text] [Related]
3. [Planning and significance of tests to confrim the presence of anti-hepatitis-C antibodies in blood donors. Spanish Study Group for Blood Donors at Risk].
León P; Echevarría JM
Sangre (Barc); 1999 Oct; 44(5):309-14. PubMed ID: 10618905
[No Abstract] [Full Text] [Related]
4. [Anti-HB-core antibodies as a surrogate marker in blood donors].
Blejer JL; Saguier MC; Salamone HJ
Sangre (Barc); 1999 Jun; 44(3):240-1. PubMed ID: 10481590
[No Abstract] [Full Text] [Related]
5. Frequency of hepatitis C virus antibodies and elevated serum alanine transaminase levels in Ghanaian blood donors.
Acquaye JK; Tettey-Donkor D
West Afr J Med; 2000; 19(4):239-41. PubMed ID: 11391831
[TBL] [Abstract][Full Text] [Related]
6. [Epidemiological information obtained from anti-hepatitis C virus screening in blood donors and candidates for autologous transfusion from 1992 to 1996 in the Alpes-Maritimes region].
Ouzan D; Pesle B; Baldini E; Rimbourg H; Darphin F; Cohen N; Brichetti A; Follana R
Gastroenterol Clin Biol; 2000 Mar; 24(3):337-41. PubMed ID: 10804343
[TBL] [Abstract][Full Text] [Related]
7. Serum pooling for screening of blood donors for hepatitis C virus antibody.
Kini S; Kumar S; Sharma RR; Thakral B; Agnihotri SK
Indian J Pathol Microbiol; 2003 Jul; 46(3):537-8. PubMed ID: 15025337
[No Abstract] [Full Text] [Related]
8. Prevalence of hepatitis B and C and blood donors.
Mehdi SR; Pophali A; Al-Abdul Rahim KA
Saudi Med J; 2000 Oct; 21(10):942-4. PubMed ID: 11369958
[TBL] [Abstract][Full Text] [Related]
9. Nucleic acid testing in blood donations reactive to hepatitis C virus antibody, but with an extremely low viral load.
Laperche S; Bouchardeau F; Maniez M; Béolet M; Elghouzzi MH; Lefrère JJ
Vox Sang; 2004 Apr; 86(3):198. PubMed ID: 15078255
[No Abstract] [Full Text] [Related]
10. Prevalence of antibodies against hepatitis B virus and hepatitis C virus among blood donors in Lebanon, 1997-2003.
Irani-Hakime N; Musharrafieh U; Samaha H; Almawi WY
Am J Infect Control; 2006 May; 34(4):241-3. PubMed ID: 16679184
[TBL] [Abstract][Full Text] [Related]
11. Predominance of antibodies to hepatitis C virus envelope proteins in various disease statuses of hepatitis C.
PodurI CD; Khanna A; Khundmiri SJ; Khaja MN; Kumar KS; Sugunan VS; Habibullah CM; Das MR
Acta Virol; 2001 Feb; 45(1):1-6. PubMed ID: 11394572
[TBL] [Abstract][Full Text] [Related]
12. Sexual transmission of the hepatitis C virus and efficacy of prophylaxis with intramuscular immune serum globulin. A randomized controlled trial.
Piazza M; Sagliocca L; Tosone G; Guadagnino V; Stazi MA; Orlando R; Borgia G; Rosa D; Abrignani S; Palumbo F; Manzin A; Clementi M
Arch Intern Med; 1997 Jul; 157(14):1537-44. PubMed ID: 9236555
[TBL] [Abstract][Full Text] [Related]
13. Hepatitis B surface antigen and anti-hepatitis C antibodies among blood donors in the Islamic Republic of Iran.
Ghavanini AA; Sabri MR
East Mediterr Health J; 2000; 6(5-6):1114-6. PubMed ID: 12197336
[TBL] [Abstract][Full Text] [Related]
14. Correlates of hepatitis C virus (HCV) RNA negativity among HCV-seropositive blood donors.
Busch MP; Glynn SA; Stramer SL; Orland J; Murphy EL; Wright DJ; Kleinman S;
Transfusion; 2006 Mar; 46(3):469-75. PubMed ID: 16533292
[TBL] [Abstract][Full Text] [Related]
15. [Detection and clinical significance of hepatitis C virus envelope protein 2 antibody].
Zhang SY; Zhang XX; Liu J; Lu M; Wang Y
Zhonghua Gan Zang Bing Za Zhi; 2002 Aug; 10(4):282. PubMed ID: 12223141
[No Abstract] [Full Text] [Related]
16. Seroprevalence of hepatitis B and C virus infections among Lao blood donors.
Jutavijittum P; Yousukh A; Samountry B; Samountry K; Ounavong A; Thammavong T; Keokhamphue J; Toriyama K
Southeast Asian J Trop Med Public Health; 2007 Jul; 38(4):674-9. PubMed ID: 17883005
[TBL] [Abstract][Full Text] [Related]
17. Risk factors and seroprevalence of hepatitis C antibody in blood donors in Nigeria.
Halim NK; Ajayi OI
East Afr Med J; 2000 Aug; 77(8):410-2. PubMed ID: 12862062
[TBL] [Abstract][Full Text] [Related]
18. [Prevalences of HIV, hepatitis B and hepatitis C in blood donors in the Republic of Djibouti].
Dray X; Dray-Spira R; Bronstein JA; Mattera D
Med Trop (Mars); 2005; 65(1):39-42. PubMed ID: 15903075
[TBL] [Abstract][Full Text] [Related]
19. Hepatitis B surface antigen, hepatitis C and HIV antibodies in a low-risk blood donor group, Nigeria.
Egah DZ; Banwat EB; Audu ES; Iya D; Mandong BM; Anele AA; Gomwalk NE
East Mediterr Health J; 2007; 13(4):961-6. PubMed ID: 17955779
[TBL] [Abstract][Full Text] [Related]
20. Markers for transfusion-associated hepatitis in north Indian blood donors: prevalence and trends.
Singh B; Verma M; Verma K
Jpn J Infect Dis; 2004 Apr; 57(2):49-51. PubMed ID: 15118208
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
